HealthCare

Quetiapine from Dr. Reddy's Laboratories will be Fully Funded by Pharmac

Dr-Reddys-LaboratoriesA drug funder of the New Zealand Government, Pharmac is ready to give funds to the Indian firm Dr. Reddy's Laboratories, which has made Quetiapine drug.

Pharmac has said that the subsidy for Seroquel, a brand of the antipsychotic drug Quetiapine will be reduced from 1 October and in its place they will introduce the new brand of Quetiapine made by the Indian pharma giant Dr. Reddy's Laboratories.

Medtronics tones down forecast despite good performance

Medtronics tones down forecast despite good performanceMedical equipment maker, Medtronics has shown better than expected profit figures but has on the same hand reduced its forecasts figures for the crest of the year.

The firm earned $830 million during the past quarter which is higher than $445 million that it was able to do during the same quarter last year. This means that against 40 cents per share the earnings have now gone up to 76 cents per share.

Medtronic to buy Osteotech

Medtronic-OsteotechWorld's largest medical device maker, Medtronic has agreed to buy out Osteotech Inc for $123 million. This company is into the business of bone grafting.

If the deal goes through then the addition of Osteotech will be done to the biologics business.

As per the news reports, Medtronic has offered to pay $6.50 per share for the company. This is 65 per cent premium on the closing share price of Osteotech of $3.94.

Ryman Inclined to Enter Australian Market

Ryman-HealthcareRyman Healthcare is planning to construct a $100 million retirement village somewhere in Melbourne and Victoria. It declared that its first village will be built in Australia.

Though, eastern seaboard was also an option with the Company, but Victoria exhibited best opportunities.

Abano Healthcare Profit Meets its Estimates

Abano-HealthcareAccording to a recent report, Abano Healthcare has declared its profit for the year, which ended in May, to be $4.4 million.

However, the profit of the specialist medical Company has witnessed a reduction of 50% as compared to the previous year.

The reason behind it is the alterations in the ACC and the sale of its Bay Audiology venture in New Zealand in last November.

Two Pathology Companies Fined for Anti-Competitive Agreement

Two Pathology Companies Fined for Anti-Competitive AgreementA sum of $100,000 will be taken as a fine from two pathology Companies, i. e., New Zealand Diagnostic Group and Pathology Associates Limited, who confessed that they entered into an anti-competitive agreement on community testing services in the Waikato.

Syndicate content